Potassium and Glucagon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Glucagon (glucagon hydrochloride). Common drug interactions include hypoxia among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Glucagon. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,148 Potassium users. Check the latest studies of Potassium.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 4,297 Glucagon users. Check the latest studies of Glucagon.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

79 people who take Potassium and Glucagon together, and have interactions are studied.

Potassium and Glucagon drug interactions.

What are the common drug interactions of Potassium and Glucagon, by gender? *:

female:

  1. Hypoxia (low oxygen in tissues)
  2. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  3. Pneumonia
  4. Pyrexia (fever)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Weight decreased
  7. Abdominal pain
  8. Acute respiratory distress syndrome
  9. Anaemia (lack of blood)
  10. Antinuclear antibody increased

male:

  1. Fall
  2. Chronic kidney disease
  3. Cardiac arrest
  4. Cellulitis (infection under the skin)
  5. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  6. Death
  7. Fatigue (feeling of tiredness)
  8. Hydrocele
  9. Lactic acidosis (low ph in body tissues)
  10. Leukocytosis (increased white blood cells)

What are the common drug interactions of Potassium and Glucagon, by age (0-1 to 60+)? *:

0-1:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective
  2. Acute leukaemia (blood cancer)

30-39:

  1. Hepatitis acute
  2. Pneumonia bacterial (pneumonia associated with bacterial infection)
  3. Abdominal pain
  4. Alopecia (absence of hair from areas of the body)
  5. Blood disorder
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Decreased appetite
  8. Depression
  9. Dizziness
  10. Fatigue (feeling of tiredness)

40-49:

  1. Cellulitis (infection under the skin)
  2. Leukocytosis (increased white blood cells)
  3. Urinary tract infection
  4. Abscess limb (limb infection)
  5. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  6. Hydrocele
  7. Necrosis (the death of body tissue)
  8. Orchitis (inflammation of the testes)
  9. Testicular abscess (pus in testes)
  10. Testicular necrosis (damaged testes)

50-59:

  1. Chronic kidney disease
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Genital abscess (build up of pus in genital)
  5. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  6. Ill-defined disorder
  7. Ketoacidosis (high concentrations of ketone bodies in blood)
  8. Lactic acidosis (low ph in body tissues)
  9. Mitral valve disease (disease of mitral valve of heart)
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Blood creatinine increased
  2. Chronic kidney disease
  3. Hypoxia (low oxygen in tissues)
  4. Cough
  5. Dizziness
  6. Hip fracture
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Pyrexia (fever)
  9. Urinary tract infection
  10. Weight decreased

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 13.92%
  2. High Blood Pressure: 11 people, 13.92%
  3. Diabetes: 10 people, 12.66%
  4. Hypoglycemia (low blood sugar): 9 people, 11.39%
  5. High Blood Cholesterol: 9 people, 11.39%
  6. Multiple Myeloma (cancer of the plasma cells): 8 people, 10.13%
  7. Pain: 7 people, 8.86%
  8. Type 2 Diabetes: 6 people, 7.59%
  9. Constipation: 6 people, 7.59%
  10. Weight Decreased: 6 people, 7.59%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Glucagon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium and Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucagon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium and glucagon hydrochloride (the active ingredients of Potassium and Glucagon, respectively), and Potassium and Glucagon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: